Australian Community Pharmacists' Preparedness to Offer and Discuss Hepatitis C Testing and Treatment With Pharmacy Clients: A Representative Cross‐Sectional Survey
Journal of Viral Hepatitis · 2025
DOI: 10.1111/jvh.70001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2025. Verfasst von Elissa Ong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Hepatitis C, Pharmacists, Community Pharmacy Services. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
The World Health Organisation (WHO) has set goals to eliminate hepatitis C (HCV) as a global health threat by 2030. To meet this goal, Australia must increase testing and diagnosis, including expanding access to care through community pharmacists. This study aims to explore community pharmacists' preparedness to discuss and offer HCV testing and treatment. Australian community pharmacists from four states completed an online anonymous quantitative survey between August and October 2023. Pharmacists were asked about their experiences of, comfort discussing and willingness to host outreach HCV testing or treatment. Predictors of each outcome were examined using logistic regression. In total, 530 pharmacists participated in the study. One in five pharmacists stocked HCV medications (22%), half (48%) were willing/somewhat willing to host an outreach HCV testing and treatment team, while 36% strongly agreed/agreed they were comfortable discussing HCV testing and treatment. Willingness to host an outreach HCV team was associated with pharmacists working in rural/remote settings (95% CI: 1.04–2.35, p = 0.032), providing opioid agonist treatment (95% CI: 1.16–2.49, p = 0.006) and comfort discussing overdose prevention (95% CI: 1.31–2.80, p = 0.001). Pharmacists with ≥ 15 years' experience (95% CI: 0.44–0.94, p = 0.022) were less willing to host outreach HCV testing. Females were significantly less comfortable discussing HCV testing (95% CI: 0.45–0.98, p = 0.039) compared to males. This is the first Australian study to explore community pharmacists' preparedness to discuss and offer HCV testing and treatment. In light of research showing that community pharmacy models of care can help meet HCV elimination targets, ongoing engagement with pharmacists is needed to increase their preparedness to provide this care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia.
- Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia.
- Department of Public Health, La Trobe University Melbourne, Victoria, Australia.
- Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
ORCID-Profile: Rose Laing, Suzanne Nielsen, Louisa Picco
Förderung
- National Health and Medical Research Council
Zitieren
APA
Ong, E., Xia, T., Laing, R., Richmond, J. A., Higgs, P., Hayes, M., Doyle, J. S., Nielsen, S., & Picco, L. (2025). Australian Community Pharmacists' Preparedness to Offer and Discuss Hepatitis C Testing and Treatment With Pharmacy Clients: A Representative Cross‐Sectional Survey. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.70001
Vancouver
Ong E, Xia T, Laing R, Richmond JA, Higgs P, Hayes M, et al. Australian Community Pharmacists' Preparedness to Offer and Discuss Hepatitis C Testing and Treatment With Pharmacy Clients: A Representative Cross‐Sectional Survey. Journal of Viral Hepatitis. 2025. doi:10.1111/jvh.70001
BibTeX
@article{Ong2025,
author = {Ong, Elissa and Xia, Ting and Laing, Rose and Richmond, Jacqueline A and Higgs, Peter and Hayes, Mark and Doyle, Joseph S and Nielsen, Suzanne and Picco, Louisa},
title = {Australian Community Pharmacists' Preparedness to Offer and Discuss Hepatitis C Testing and Treatment With Pharmacy Clients: A Representative Cross‐Sectional Survey},
journal = {Journal of Viral Hepatitis},
year = {2025},
doi = {10.1111/jvh.70001}
}
EUVIMED